Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects

Published on Aug 1, 2011in British Journal of Pharmacology7.73
· DOI :10.1111/J.1476-5381.2011.01238.X
Ethan B. Russo25
Estimated H-index: 25
(GW Pharmaceuticals)
Sources
Abstract
Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other phytocannabinoids, including tetrahydrocannabivarin, cannabigerol and cannabichromene, exert additional effects of therapeutic interest. Innovative conventional plant breeding has yielded cannabis chemotypes expressing high titres of each component for future study. This review will explore another echelon of phytotherapeutic agents, the cannabis terpenoids: limonene, myrcene, α-pinene, linalool, β-caryophyllene, caryophyllene oxide, nerolidol and phytol. Terpenoids share a precursor with phytocannabinoids, and are all flavour and fragrance components common to human diets that have been designated Generally Recognized as Safe by the US Food and Drug Administration and other regulatory agencies. Terpenoids are quite potent, and affect animal and even human behaviour when inhaled from ambient air at serum levels in the single digits ng·mL−1. They display unique therapeutic effects that may contribute meaningfully to the entourage effects of cannabis-based medicinal extracts. Particular focus will be placed on phytocannabinoid-terpenoid interactions that could produce synergy with respect to treatment of pain, inflammation, depression, anxiety, addiction, epilepsy, cancer, fungal and bacterial infections (including methicillin-resistant Staphylococcus aureus). Scientific evidence is presented for non-cannabinoid plant components as putative antidotes to intoxicating effects of THC that could increase its therapeutic index. Methods for investigating entourage effects in future experiments will be proposed. Phytocannabinoid-terpenoid synergy, if proven, increases the likelihood that an extensive pipeline of new therapeutic products is possible from this venerable plant. LINKED ARTICLES This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue-7
Figures & Tables
Download
📖 Papers frequently viewed together
671 Citations
534 Citations
799 Citations
References275
Newest
#1Maria Grazia Cascio (Aberd.: University of Aberdeen)H-Index: 20
#2Roger G. Pertwee (Aberd.: University of Aberdeen)H-Index: 83
Last. Pietro Marini (Aberd.: University of Aberdeen)H-Index: 15
view all 3 authors...
The plant Cannabis sativa has been widely used by humans over many centuries as a source of fibre, for medicinal purposes, for religious ceremonies and as a recreational drug. Since the discovery of its main psychoactive ingredient, Δ9-tetrahydrocannabinol (THC), significant progress has been made towards the understanding (1) of the in vitro and in vivo pharmacology both of THC and of certain other cannabis-derived compounds, and (2) of the potential and actual uses of these “phytocannabinoids”...
68 CitationsSource
#1Yoshiaki NomaH-Index: 16
#2Yoshinori AsakawaH-Index: 3
16 CitationsSource
#1Chlodwig FranzH-Index: 24
#2Johannes NovakH-Index: 28
60 CitationsSource
#1Maria Lis-BalchinH-Index: 1
8 CitationsSource
#1Robert HarrisH-Index: 1
9 CitationsSource
#1Erich SchmidtH-Index: 1
#1Erich SchmidtH-Index: 21
33 CitationsSource
#1Navarro GarcíaH-Index: 1
#2María AngelesH-Index: 1
Edicion del texto arabe y traduccion espanola de un fragmento de una obra medico-botanica, ordenada alfabeticamente, llevada a cabo por un autor malagueno del siglo XIII, de gran valor. El fragmento corresponde a la letra ba. El trabajo se complementa con indices y bibliografia, precedido, todo ello, por un estudio del autor y la obra objeto del trabajo. Destaca el aparato critico.
2 Citations
#1Fitz Hugh LudlowH-Index: 1
#1Stephen RachmanH-Index: 4
Last. Fitz Hugh LudlowH-Index: 1
view all 2 authors...
7 Citations
2 Citations
BACKGROUND AND PURPOSE Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) interact with transient receptor potential (TRP) channels and enzymes of the endocannabinoid system. EXPERIMENTAL APPROACH The effects of 11 pure cannabinoids and botanical extracts [botanical drug substance (BDS)] from Cannabis varieties selected to contain a more abundant cannabinoid, on TRPV1, TRPV2, TRPM8, TRPA1, human recombinant diacylglycerol lipase α (DAGLα), rat brain fatty acid amide hydrolase (FAAH), COS cell m...
416 CitationsSource
Cited By618
Newest
#1Andrea CerratoH-Index: 6
#2Cinzia CittiH-Index: 11
Last. Aldo LaganàH-Index: 47
view all 11 authors...
Abstract Cannabis sativa is traditionally classified according to five chemotypes based on the concentration of the main phytocannabinoids tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabigerol (CBG). However, cannabis chemovars and varieties very often present similar concentrations of such phytocannabinoids but different chemical profiles, which is unavoidably translated into different pharmacological effects when used for therapeutic purposes. For this reason, a more refined approach...
Source
#1Tao Fei (UT: University of Tennessee)H-Index: 6
#2Zifan Wan (UT: University of Tennessee)
Last. Tong Wang (UT: University of Tennessee)H-Index: 2
view all 3 authors...
ABSTRACT Insoluble yolk low-density lipoprotein (LDL) recovered by complexing with carboxymethylcellulose (CMC) was studied as an encapsulation agent for nanoencapsulation formulation at neutral pH. The effect of emulsifier and defatting on the dispersibility of the LDL-CMC complex was investigated. A novel dispersion containing partially defatted LDL, CMC, low quantity of Tween 80 and sodium lauryl sulfate (SLS) were successfully created and investigated for encapsulating lipophilic terpenes-ca...
Source
#1Mazen M. El-Hammadi (University of Seville)H-Index: 8
Last. Lucía Martín-Banderas (University of Seville)H-Index: 14
view all 4 authors...
Abstract Terpenes derived from different varieties of Cannabis sativa have shown potentially useful pharmacological activities, including the ability to bind to transient receptor potential (TRP) channels. Beta-myrcene (MC), beta-caryophyllene (CPh), and nerolidol (NL) are among the most abundant and studied terpenes found in cannabis. Despite the potential pharmacological effectiveness of these terpenes, their volatile and hydrophobic nature, and associated poor solubility and low bioavailabili...
Source
#1Wassim N. Shebaby (Lebanese American University)H-Index: 9
#2Jane Saliba (Lebanese American University)
Last. Mohamad Mroueh (Lebanese American University)H-Index: 13
view all 11 authors...
Ethnopharmacological relevance Cannabis sativa L. is an aromatic annual herb belonging to the family Cannabaceae and it is widely distributed worldwide. Cultivation, selling, and consumption of cannabis and cannabis related products, regardless of its use, was prohibited in Lebanon until April 22, 2020. Nevertheless, cannabis oil has been traditionally used unlawfully for many years in Lebanon to treat diseases such as arthritis, diabetes, cancer and few neurological disorders. Aim of the study ...
Source
#1Nancy De BriyneH-Index: 1
#1Nancy De BriyneH-Index: 1
Last. Arturo Anadón (Complutense University of Madrid)H-Index: 31
view all 8 authors...
As cannabis-derived products have become more available, veterinarians are seeing more cases of toxicosis. In addition, animal owners are having an increasing interest in using these products for their pets. This review looks at the situation in Europe and North America, the different types of cannabis and cannabis-derived products with historical examples of use in animals, and the cannabis industry. The existing regulatory framework for use in humans and animals as medicines and/or supplements...
Source
#1Emily Bonner (OSU: Oregon State University)
#2Yvonne Chang (OSU: Oregon State University)H-Index: 1
Last. Robyn L. Tanguay (OSU: Oregon State University)H-Index: 3
view all 21 authors...
Abstract Vaping is the process of inhaling and exhaling an aerosol produced by an e-cigarette, vape pen, or personal aerosolizer. When the device contains nicotine, the Food and Drug Administration (FDA) lists the product as an electronic nicotine delivery system or ENDS device. Similar electronic devices can be used to vape cannabis extracts. Over the past decade, the vaping market has increased exponentially, raising health concerns over the number of people exposed and a nationwide outbreak o...
Source
Source
#1Alex Mabou Tagne (UCI: University of California, Irvine)
#1Alex Mabou Tagne (UCI: University of California, Irvine)H-Index: 2
Last. Daniele Piomelli (UCI: University of California, Irvine)H-Index: 95
view all 8 authors...
ABSTRACT The use of products derived from hemp – i.e., cannabis varieties with low Δ9-tetrahydrocannabinol (Δ9-THC) content – as self-medication for pain and other health conditions is gaining in popularity but preclinical and clinical evidence for their effectiveness remains very limited. In the present study, we assessed the efficacy of a full-spectrum hemp oil extract (HOE; 10, 50 and 100 mg-kg-1; oral route), alone or in combination with the anti-inflammatory and analgesic agent palmitoyleth...
1 CitationsSource